HS-tk vector injected into tumor cells to express the gene for thymidine kinase: Began a Phase I/II trial with partner Sandoz Pharma Ltd. in six patients, with

Genetic Therapy Inc. (GTII), Gaithersburg,

Read the full 57 word article

How to gain access

Continue reading with a
two-week free trial.